Literature DB >> 21168432

Sulfation of chlorotyrosine and nitrotyrosine by human lung endothelial and epithelial cells: role of the human SULT1A3.

Shin Yasuda1, Tomoko Yasuda, Ming-Yih Liu, Sreerama Shetty, Steven Idell, Vijayakumar Boggaram, Masahito Suiko, Yoichi Sakakibara, Jian Fu, Ming-Cheh Liu.   

Abstract

During inflammation, potent reactive oxidants formed may cause chlorination and nitration of both free and protein-bound tyrosine. In addition to serving as biomarkers of inflammation-mediated oxidative stress, elevated levels of chlorotyrosine and nitrotyrosine have been linked to the pathogenesis of lung and vascular disorders. The current study was designed to investigate whether the lung cells are equipped with mechanisms for counteracting these tyrosine derivatives. By metabolic labeling, chlorotyrosine O-[³⁵S]sulfate and nitrotyrosine O-[³⁵S]sulfate were found to be generated and released into the labeling media of human lung endothelial and epithelial cells labeled with [³⁵S]sulfate in the presence of added chlorotyrosine and nitrotyrosine. Enzymatic assays using the eleven known human cytosolic sulfotransferases (SULTs) revealed SULT1A3 as the enzyme responsible for catalyzing the sulfation of chlorotyrosine and nitrotyrosine. Reverse transcription-polymerase chain reaction (RT-PCR) analysis demonstrated the expression of SULT1A3 in the lung endothelial and epithelial cells used in this study. Kinetic constants of the sulfation of chlorotyrosine and nitrotyrosine by SULT1A3 were determined. Collectively, these results suggest that sulfation by SULT1A3 in lung endothelial and epithelial cells may play a role in the inactivation and/or disposal of excess chlorotyrosine and nitrotyrosine generated during inflammation.
Copyright © 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21168432     DOI: 10.1016/j.taap.2010.12.006

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  4 in total

Review 1.  L-tyrosine and L-dihydroxyphenylalanine as hormone-like regulators of melanocyte functions.

Authors:  Andrzej Slominski; Michal A Zmijewski; John Pawelek
Journal:  Pigment Cell Melanoma Res       Date:  2011-09-02       Impact factor: 4.693

2.  An insight into the transcriptome of the digestive tract of the bloodsucking bug, Rhodnius prolixus.

Authors:  José M C Ribeiro; Fernando A Genta; Marcos H F Sorgine; Raquel Logullo; Rafael D Mesquita; Gabriela O Paiva-Silva; David Majerowicz; Marcelo Medeiros; Leonardo Koerich; Walter R Terra; Clélia Ferreira; André C Pimentel; Paulo M Bisch; Daniel C Leite; Michelle M P Diniz; João Lídio da S G V Junior; Manuela L Da Silva; Ricardo N Araujo; Ana Caroline P Gandara; Sébastien Brosson; Didier Salmon; Sabrina Bousbata; Natalia González-Caballero; Ariel Mariano Silber; Michele Alves-Bezerra; Katia C Gondim; Mário Alberto C Silva-Neto; Georgia C Atella; Helena Araujo; Felipe A Dias; Carla Polycarpo; Raquel J Vionette-Amaral; Patrícia Fampa; Ana Claudia A Melo; Aparecida S Tanaka; Carsten Balczun; José Henrique M Oliveira; Renata L S Gonçalves; Cristiano Lazoski; Rolando Rivera-Pomar; Luis Diambra; Günter A Schaub; Elói S Garcia; Patrícia Azambuja; Glória R C Braz; Pedro L Oliveira
Journal:  PLoS Negl Trop Dis       Date:  2014-01-09

Review 3.  SULT genetic polymorphisms: physiological, pharmacological and clinical implications.

Authors:  Katsuhisa Kurogi; Mohammed I Rasool; Fatemah A Alherz; Amal A El Daibani; Ahsan F Bairam; Maryam S Abunnaja; Shin Yasuda; Lauren J Wilson; Ying Hui; Ming-Cheh Liu
Journal:  Expert Opin Drug Metab Toxicol       Date:  2021-06-30       Impact factor: 4.936

4.  Co-inhibition of HDAC and MLL-menin interaction targets MLL-rearranged acute myeloid leukemia cells via disruption of DNA damage checkpoint and DNA repair.

Authors:  Jing Ye; Jie Zha; Yuanfei Shi; Yin Li; Delin Yuan; Qinwei Chen; Fusheng Lin; Zhihong Fang; Yong Yu; Yun Dai; Bing Xu
Journal:  Clin Epigenetics       Date:  2019-10-07       Impact factor: 6.551

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.